Search all trials

Find therapies in clinical trials near you – page 30

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hypercholesterolaemia

Not recruiting

Registered drugNo placebo

Study Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Gastrointestinal melanoma+7

Not recruiting

Registered drug

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Post-acute COVID-19 syndrome

Not recruiting

Investigational

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Vidofludimus Calcium

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Bendamustine, Obinutuzumab, Zanubrutinib, and Venetoclax for Patients with Relapsed Chronic Lymphocytic Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

B-cell lymphoma+2

Not recruiting

InvestigationalNo placebo

Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lisocabtagene Maraleucel

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Brodalumab

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Asciminib

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Crohn's disease

Not recruiting

InvestigationalNo placebo

Long-term study of upadacitinib tablets for adults with Crohn's disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Squamous cell carcinoma of skin

Not recruiting

Registered drug

Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Find therapies in clinical trials near you – page 30

434 trials match your criteria

Hypercholesterolaemia

Study Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease

Gastrointestinal melanoma+7

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Post-acute COVID-19 syndrome

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Chronic lymphocytic leukaemia

Study on Bendamustine, Obinutuzumab, Zanubrutinib, and Venetoclax for Patients with Relapsed Chronic Lymphocytic Leukemia

B-cell lymphoma+2

Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

Non-small cell lung cancer

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Psoriasis

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Dermatitis atopic

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Chronic myeloid leukaemia

Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

Colitis ulcerative

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Crohn's disease

Long-term study of upadacitinib tablets for adults with Crohn's disease

Squamous cell carcinoma of skin

Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.